CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CLVSEUR | Clovis Oncology INC | Stock-Other | 53.20% | — | — | |
| 2 | FPRX | Five Prime Therapeutics INC | Stock-Other | 21.95% | — | — | |
| 3 | AKAOQ | Achaogen INC | Stock-Other | 11.00% | — | — | |
| 4 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 6.38% | — | — | |
| 5 | INGN | Inogen INC | Stock-Other | 4.37% | — | — | |
| 6 | ✓ | Kythera Biopharmaceuticals I | Stock-Other | 3.10% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CLVSEUR | Clovis Oncology INC | +9.6% | — | Unchanged |
| 2 | ✓ | Kythera Biopharmaceuticals I | +0.8% | — | Unchanged |
| 3 | CBAYUSD | Cymabay Therapeutics INC | -3.5% | — | Unchanged |
| 4 | AKAOQ | Achaogen INC | -5% | — | Unchanged |
| 5 | FPRX | Five Prime Therapeutics INC | -6.3% | — | Unchanged |
| 6 | INGN | Inogen INC | — | NEW | New buy |